المؤلفون: Amant, F, Berveiller, P, Boere, IA, Cardonick, E, Fruscio, R, Fumagalli, M, Halaska, MJ, Hasenburg, A, Johansson, ALV, Lambertini, M, Lok, CAR, Maggen, C, Morice, P, Peccatori, F, Poortmans, P, Van Calsteren, K, Vandenbroucke, T, van Gerwen, M, van den Heuvel-Eibrink, M, Zagouri, F, Zapardiel, I

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 30(10):1601-1612

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:142772482

المؤلفون: Monk, BJ, Van Gorp, T, Lorusso, D, O'Cearbhaill, RE, Westermann, AM, Banerjee, S, Collins, DC, Klat, J, Madsen, K, Baurain, JF, Jackson, A, Boere, IA, Pignata, S, Gort, E, Moroney, J, Soumaoro, I, Mondrup Andreassen, C, Nicacio, LV, GENNIGENS, Christine, Vergote, I

مصطلحات موضوعية: Tisotumab, Bevacizumab, Pembrolizumab, Human health sciences :: Oncology, Sciences de la santé humaine :: Oncologie

Relation: 2021 IGCS Annual Global Meeting; August 30-September 2, 2021; virtual. Plenary 5 (August 30-September 2,2021)

URL الوصول: https://orbi.uliege.be/handle/2268/264607

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Stroot IAS; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands. Electronic address: i.a.s.stroot@umcg.nl., Bart J; University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, the Netherlands., Hollema H; University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, the Netherlands., Jalving M; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, the Netherlands., Wagner MM; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands., Yigit R; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands., van Doorn HC; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Gynecologic Oncology, Rotterdam, the Netherlands., de Hullu JA; Radboud University Medical Center, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., Gaarenstroom KN; Leiden University Medical Center, Department of Obstetrics and Gynecology, Leiden, the Netherlands., van Beurden M; Antoni van Leeuwenhoek, Department of Gynecology, Amsterdam, the Netherlands., van Lonkhuijzen LRCW; Amsterdam University Medical Center-Center for Gynecological Oncology Amsterdam, Department of Gynecologic Oncology, Amsterdam, the Netherlands., Slangen BFM; Maastricht University Medical Center, Department of Gynecology, Maastricht, the Netherlands., Zweemer RP; University Medical Center Utrecht, Department of Gynecologic Oncology, Utrecht, the Netherlands., Gómez García EB; University Medical Center Maastricht, Department of Clinical Genetics, Maastricht, the Netherlands., Ausems MGEM; University Medical Center Utrecht, Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, Utrecht, the Netherlands., Boere IA; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, the Netherlands., van Hest LP; Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Human Genetics, Amsterdam, the Netherlands., Duijkers FAM; Amsterdam UMC, University of Amsterdam, Department of Human Genetics, Amsterdam, the Netherlands., van Asperen CJ; Leiden University Medical Center, Department of Human Genetics & Department of Pathology, Leiden, the Netherlands., Schmidt MK; Leiden University Medical Center, Department of Human Genetics & Department of Pathology, Leiden, the Netherlands; Netherlands Cancer Institute, Department of Epidemiology, Amsterdam, the Netherlands; Netherlands Cancer Institute, Division of Molecular Pathology, Amsterdam, the Netherlands., Wevers MR; Radboud University Medical Center, Department of Clinical Genetics, Nijmegen, the Netherlands., Ruijs MWG; Netherlands Cancer Institute, Department of Clinical Genetics, Amsterdam, the Netherlands., Devilee P; Leiden University Medical Center, Department of Human Genetics & Department of Pathology, Leiden, the Netherlands., Collée JM; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, the Netherlands., Hebon Investigators; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating Center: Netherlands Cancer Institute, Amsterdam, the Netherlands., de Bock GH; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands., Mourits MJE; University of Groningen, University Medical Center Groningen, Department of Gynecologic Oncology, Groningen, the Netherlands.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Aug; Vol. 187, pp. 198-203. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Salpingo-oophorectomy* , Germ-Line Mutation* , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/pathology , Ovarian Neoplasms*/surgery , Cystadenocarcinoma, Serous*/genetics , Cystadenocarcinoma, Serous*/pathology , Cystadenocarcinoma, Serous*/surgery, Humans ; Female ; Middle Aged ; Adult ; Aged ; BRCA2 Protein/genetics ; BRCA1 Protein/genetics ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/prevention & control ; Genes, BRCA2 ; Disease-Free Survival ; Genes, BRCA1 ; Heterozygote ; Neoplasm Grading

المؤلفون: Zelisse HS; Department of Pathology, Cancer Center Amsterdam, Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., de Ridder S; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Gent MDJM; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Mom CH; Department of Gynaecologic Oncology, Centre for Gynaecologic Oncology Amsterdam, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Wisman GBA; Department of Gynaecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Roes EM; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Reyners AKL; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Piek JM; Department of Obstetrics and Gynaecology, Catharina Hospital, Catharina Cancer Institute, Eindhoven, the Netherlands., Nieuwenhuyzen-de Boer GM; Department of Gynaecology and Obstetrics, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Lok CAR; Department of Gynaecological Oncology, Centre for Gynaecologic Oncology Amsterdam, Antoni van Leeuwenhoek, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Kroon CD; Department of Obstetrics and Gynaecology, Leiden University Medical Center, Leiden, the Netherlands., Kooreman LFS; Department of Pathology and GROW, School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., Janssen MJ; Department of Gynecological Oncology, Medisch Spectrum Twente, Enschede, the Netherlands., Jansen MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Collée M; Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Broeks A; Department of CFMPB (Core Facility - Molecular Pathology and Biobanking), The Netherlands Cancer Institute, Amsterdam, the Netherlands., Boere IA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Bart J; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van Altena AM; Department of Obstetrics & Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands., Heeling M; Department of Pathology, Cancer Center Amsterdam, Amsterdam Reproduction & Development Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Stoter IM; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Voorham QJ; Palga Foundation, Houten, the Netherlands., van de Vijver MJ; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Dijk F; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Belien JAM; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

مؤلفون مشاركون: Archipelago of Ovarian Cancer Research Consortium

المصدر: Biopreservation and biobanking [Biopreserv Biobank] 2024 Apr 29. Date of Electronic Publication: 2024 Apr 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 101507284 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1947-5543 (Electronic) Linking ISSN: 19475543 NLM ISO Abbreviation: Biopreserv Biobank Subsets: MEDLINE

المؤلفون: Xu T; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Verhagen MP; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Teeuwssen M; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands.; Elisabeth-TweeSteden Ziekenhuis (ETZ), Tilburg, The Netherlands., Sun W; Institut Curie, Laboratory of Genetics and Developmental Biology, Paris, France., Joosten R; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Sacchetti A; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Ewing-Graham PC; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Jansen MPHM; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands., Boere IA; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands., Bryce NS; School of Biomedical Sciences, Faculty of Medicine and Health, The University of New South Wales, Sydney, New South Wales, Australia.; The Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia., Zeng J; Computist Bio-NanoTech, Scoresby, VIC, 3179, Australia., Treutlein HR; Computist Bio-NanoTech, Scoresby, VIC, 3179, Australia.; Sanoosa Pty. Ltd, Moonee Ponds, VIC, 3039, Australia., Hook J; School of Biomedical Sciences, Faculty of Medicine and Health, The University of New South Wales, Sydney, New South Wales, Australia., Hardeman EC; School of Biomedical Sciences, Faculty of Medicine and Health, The University of New South Wales, Sydney, New South Wales, Australia., Gunning PW; School of Biomedical Sciences, Faculty of Medicine and Health, The University of New South Wales, Sydney, New South Wales, Australia., Fodde R; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands. r.fodde@erasmusmc.nl.

المصدر: Cell death and differentiation [Cell Death Differ] 2024 Mar; Vol. 31 (3), pp. 360-377. Date of Electronic Publication: 2024 Feb 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9437445 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5403 (Electronic) Linking ISSN: 13509047 NLM ISO Abbreviation: Cell Death Differ Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/genetics , Ovarian Neoplasms*/metabolism, Humans ; Female ; Cell Movement ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; Wnt Signaling Pathway ; Epithelial-Mesenchymal Transition ; RNA-Binding Proteins/metabolism

المؤلفون: Servayge J; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, 3000 CA Rotterdam, The Netherlands., Olthof EP; Department of Gynecologic Oncology, Amsterdam University Medical Centre, Centre for Gynecologic Oncology Amsterdam (CGOA), 1066 CX Amsterdam, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), 3501 DB Utrecht, The Netherlands., Mom CH; Department of Gynecologic Oncology, Amsterdam University Medical Centre, Centre for Gynecologic Oncology Amsterdam (CGOA), 1066 CX Amsterdam, The Netherlands., van der Aa MA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), 3501 DB Utrecht, The Netherlands., Wenzel HHB; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), 3501 DB Utrecht, The Netherlands., van der Velden J; Department of Gynecologic Oncology, Amsterdam University Medical Centre, Centre for Gynecologic Oncology Amsterdam (CGOA), 1066 CX Amsterdam, The Netherlands., Nout RA; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, 3000 CA Rotterdam, The Netherlands., Boere IA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, 3000 CA Rotterdam, The Netherlands., van Doorn HC; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, 3000 CA Rotterdam, The Netherlands., van Beekhuizen HJ; Department of Gynecologic Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, 3000 CA Rotterdam, The Netherlands.

المصدر: Cancers [Cancers (Basel)] 2024 Feb 01; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, Leuven, Belgium., Van Nieuwenhuysen E; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven Cancer Institute, Leuven, Belgium., O'Cearbhaill RE; Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY., Westermann A; Dutch Gynaecological Oncology Group, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Lorusso D; Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Catholic University of Sacred Heart, Rome, Italy., Ghamande S; Department of Obstetrics and Gynecology, Augusta University, Augusta, GA., Collins DC; Department of Medical Oncology, Cancer Trials Ireland, Cork University Hospital, Cork, Ireland., Banerjee S; Royal Marsden National Health Service Foundation Trust, Institute of Cancer Research, London, United Kingdom., Mathews CA; Program in Women's Oncology, Women & Infants Hospital, Legorreta Cancer Center at Alpert Medical School of Brown University, Providence, RI., Gennigens C; BGOG, Centre Hospitalier Universitaire de Liège, Liège, Belgium., Cibula D; Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic., Tewari KS; University of California, Irvine, CA., Madsen K; Centre for Cancer and Organ Diseases, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Köse F; Baskent University, Ankara, Turkey., Jackson AL; Department of Obstetrics and Gynecology, University of Cincinnati Cancer Center, Cincinnati, OH., Boere IA; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Scambia G; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy., Randall LM; School of Medicine, Virginia Commonwealth University, Richmond, VA., Sadozye A; Beatson West of Scotland Cancer Centre, Gartnavel General Hospital, Glasgow, United Kingdom., Baurain JF; Cliniques Universitaires Saint-Luc and Université Catholique de Louvain and BGOG, Brussels, Belgium., Gort E; University Medical Center Utrecht, Utrecht, the Netherlands., Zikán M; First Faculty of Medicine, Bulovka University Hospital, Charles University, Prague, Czech Republic., Denys HG; BGOG, Ghent University Hospital, Ghent, Belgium., Ottevanger N; Radboudumc, Nijmegen, the Netherlands., Forget F; BGOG, Centre Hospitalier de l'Ardenne-Site de Libramont, Libramont-Chevigny, Belgium., Mondrup Andreassen C; Genmab A/S, Copenhagen, Denmark., Eaton L; Genmab US, Princeton, NJ., Chisamore MJ; Merck & Co, Inc, Rahway, NJ., Viana Nicacio L; Seagen, Bothell, WA., Soumaoro I; Genmab US, Princeton, NJ., Monk BJ; HonorHealth Research Institute, University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Dec 20; Vol. 41 (36), pp. 5536-5549. Date of Electronic Publication: 2023 Aug 31.

نوع المنشور: Multicenter Study; Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Uterine Cervical Neoplasms*/drug therapy , Lung Neoplasms*/drug therapy , Anemia*/drug therapy, Female ; Humans ; Bevacizumab/adverse effects ; Carboplatin/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoplasm Recurrence, Local/etiology

المؤلفون: van der Ploeg P; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Hendrikse CS; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Thijs AM; Department of Internal Medicine and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., Smedts HP; Department of Obstetrics and Gynaecology, Amphia Hospital, Breda, the Netherlands., Vos MC; Department of Obstetrics and Gynaecology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands., Jalving M; Department of Medical Oncology, University Medical Centre Groningen, Groningen, the Netherlands., Lok CA; Department of Gynaecologic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Boere IA; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Rotterdam, the Netherlands., van Ham MA; Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, the Netherlands., Ottevanger PB; Department of Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands., Westermann AM; Department of Oncology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Mom CH; Department of Obstetrics and Gynaecology, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Lalisang RI; Department of Medical Oncology, Maastricht University Medical Centre +, Maastricht, the Netherlands., Lambrechts S; Department of Obstetrics and Gynaecology, Maastricht University Medical Centre +, Maastricht, the Netherlands., Bekkers RL; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.; GROW School for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands., Piek JM; Department of Obstetrics and Gynaecology and Catharina Cancer Institute, Catharina Hospital, Eindhoven, the Netherlands.

المصدر: Heliyon [Heliyon] 2023 Dec 01; Vol. 10 (1), pp. e23170. Date of Electronic Publication: 2023 Dec 01 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE